GWAS on family history of Alzheimer’s disease

Alzheimer’s disease (AD) is a public health priority for the 21st century. Risk reduction currently revolves around lifestyle changes with much research trying to elucidate the biological underpinnings. We show that self-report of parental history of Alzheimer’s dementia for case ascertainment in a genome-wide association study of 314,278 participants from UK Biobank (27,696 maternal cases, 14,338 paternal cases) is a valid proxy for an AD genetic study. After meta-analysing with published consortium data (n = 74,046 with 25,580 cases across the discovery and replication analyses), three new AD-associated loci (P < 5 × 10−8) are identified. These contain genes relevant for AD and neurodegeneration: ADAM10, BCKDK/KAT8 and ACE. Novel gene-based loci include drug targets such as VKORC1 (warfarin dose). We report evidence that the association of SNPs in the TOMM40 gene with AD is potentially mediated by both gene expression and DNA methylation in the prefrontal cortex. However, it is likely that multiple variants are affecting the trait and gene methylation/expression. Our discovered loci may help to elucidate the biological mechanisms underlying AD and, as they contain genes that are drug targets for other diseases and disorders, warrant further exploration for potential precision medicine applications.

[1]  Ace Inhibitors: Central Actions , 1994 .

[2]  S. Johnston,et al.  Alzheimer disease risk and genetic variation in ACE , 2004, Neurology.

[3]  A. Hofman,et al.  ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala , 2005, Neurobiology of Aging.

[4]  K. Sleegers,et al.  Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. , 2005, American journal of epidemiology.

[5]  S. Hunt,et al.  Common VKORC1 and GGCX polymorphisms associated with warfarin dose , 2005, The Pharmacogenomics Journal.

[6]  Nicole Soranzo,et al.  A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose , 2009, PLoS genetics.

[7]  K. Elliott,et al.  Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. , 2009, Human molecular genetics.

[8]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[9]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[10]  P. Visscher,et al.  Common SNPs explain a large proportion of heritability for human height , 2011 .

[11]  L. Mucke,et al.  Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.

[12]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[13]  W. M. van der Flier,et al.  The association of angiotensin-converting enzyme with biomarkers for Alzheimer’s disease , 2014, Alzheimer's Research & Therapy.

[14]  R. Tanzi,et al.  ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function , 2013, Neuron.

[15]  Perry G. Ridge,et al.  Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation , 2014, PLoS genetics.

[16]  Convergent genetic and expression data implicate immunity in Alzheimer's disease , 2015, Alzheimer's & Dementia.

[17]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[18]  M. Daly,et al.  An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.

[19]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[20]  Mitchell J. Machiela,et al.  LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..

[21]  L. Wain,et al.  Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank , 2015, The Lancet. Respiratory medicine.

[22]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[23]  Christine Van Broeckhoven,et al.  The genetic landscape of Alzheimer disease: clinical implications and perspectives , 2015, Genetics in Medicine.

[24]  P. Visscher,et al.  Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.

[25]  Magda Tsolaki,et al.  A NOVEL ALZHEIMER DISEASE LOCUS LOCATED NEAR THE GENE ENCODING TAU PROTEIN , 2015, Molecular Psychiatry.

[26]  O. Andreassen,et al.  Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  Daniel R Weinberger,et al.  Mapping DNA methylation across development, genotype, and schizophrenia in the human frontal cortex , 2015, Nature Neuroscience.

[28]  I. Deary,et al.  Dementia ascertainment using existing data in UK longitudinal and cohort studies: a systematic review of methodology , 2017, BMC Psychiatry.

[29]  Robert M. Maier,et al.  Causal associations between risk factors and common diseases inferred from GWAS summary data , 2017, Nature Communications.

[30]  H. Schmidt,et al.  Genetics of vascular dementia – review from the ICVD working group , 2017, BMC Medicine.

[31]  Erdogan Taskesen,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[32]  L. Tan,et al.  The Role of ADAM10 in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[33]  Yaniv Erlich,et al.  Case–control association mapping by proxy using family history of disease , 2017, Nature Genetics.

[34]  P. Donnelly,et al.  Genome-wide genetic data on ~500,000 UK Biobank participants , 2017, bioRxiv.

[35]  Luke R. Lloyd-Jones,et al.  Transformation of Summary Statistics from Linear Mixed Model Association on All-or-None Traits to Odds Ratio , 2018, Genetics.

[36]  Mitchell J. Machiela,et al.  LDassoc: an online tool for interactively exploring genome-wide association study results and prioritizing variants for functional investigation , 2018, Bioinform..